He has demonstrated that artificial intelligence is significantly more accurate than blood tests in predicting the survival rates of ovarian cancer. For the study, Aboagye used TexLab to analyse CT scans and establish the health risks associated with different tumours. The software was trained to analyse the shape, size, genetic composition and structure of tumours. Aboagye have developed imaging tools capable of characterising choline, glycogen and fatty acid metabolism.
